Van Hersenen tot Bloed: Het Gebruik van Bloedtesten voor Toegankelijke Diagnose, Prognose en Monitoring van de Ziekte van Alzheimer

As a primary objective we will develop and validate blood-based immunoassays on a newly developed automated platform in patients with Alzheimer's disease as well as cognitively healthy elderly and disease controls. An additional, clinical objective is to link the quantified blood biomarkers to brain pathology, clinical parameters as well as brain imaging. Besides, I will take part in a multicenter study concerning the application of machine learning for brain image classification.